Cargando…
Trochleoplasty is a Viable Option for Patellar Instability in Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective Study
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664632/ http://dx.doi.org/10.1177/2325967119S00305 |
_version_ | 1783439922537955328 |
---|---|
author | Carstensen, S. Evan Burrus, Matthew Tyrrell Feeley, Scott Cancienne, Jourdan M. Diduch, David R. |
author_facet | Carstensen, S. Evan Burrus, Matthew Tyrrell Feeley, Scott Cancienne, Jourdan M. Diduch, David R. |
author_sort | Carstensen, S. Evan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6664632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-66646322019-08-05 Trochleoplasty is a Viable Option for Patellar Instability in Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective Study Carstensen, S. Evan Burrus, Matthew Tyrrell Feeley, Scott Cancienne, Jourdan M. Diduch, David R. Orthop J Sports Med Article SAGE Publications 2019-07-29 /pmc/articles/PMC6664632/ http://dx.doi.org/10.1177/2325967119S00305 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For article reuse guidelines, please visit SAGE’s website at http://www.sagepub.com/journals-permissions. |
spellingShingle | Article Carstensen, S. Evan Burrus, Matthew Tyrrell Feeley, Scott Cancienne, Jourdan M. Diduch, David R. Trochleoplasty is a Viable Option for Patellar Instability in Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective Study |
title | Trochleoplasty is a Viable Option for Patellar Instability in
Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective
Study |
title_full | Trochleoplasty is a Viable Option for Patellar Instability in
Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective
Study |
title_fullStr | Trochleoplasty is a Viable Option for Patellar Instability in
Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective
Study |
title_full_unstemmed | Trochleoplasty is a Viable Option for Patellar Instability in
Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective
Study |
title_short | Trochleoplasty is a Viable Option for Patellar Instability in
Patients with Severe Trochlear Dysplasia: a Minimum 1-year Follow-Up Prospective
Study |
title_sort | trochleoplasty is a viable option for patellar instability in
patients with severe trochlear dysplasia: a minimum 1-year follow-up prospective
study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664632/ http://dx.doi.org/10.1177/2325967119S00305 |
work_keys_str_mv | AT carstensensevan trochleoplastyisaviableoptionforpatellarinstabilityinpatientswithseveretrochleardysplasiaaminimum1yearfollowupprospectivestudy AT burrusmatthewtyrrell trochleoplastyisaviableoptionforpatellarinstabilityinpatientswithseveretrochleardysplasiaaminimum1yearfollowupprospectivestudy AT feeleyscott trochleoplastyisaviableoptionforpatellarinstabilityinpatientswithseveretrochleardysplasiaaminimum1yearfollowupprospectivestudy AT canciennejourdanm trochleoplastyisaviableoptionforpatellarinstabilityinpatientswithseveretrochleardysplasiaaminimum1yearfollowupprospectivestudy AT diduchdavidr trochleoplastyisaviableoptionforpatellarinstabilityinpatientswithseveretrochleardysplasiaaminimum1yearfollowupprospectivestudy |